| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 1,738.2 | 2,028.4 | 1,988.4 | 2,419.2 |
yoy growth (%) | -14.3 | 2.01 | -17.8 | -6.51 |
Raw materials | -808.2 | -798.3 | -827.7 | -1,049.4 |
As % of sales | 46.49 | 39.35 | 41.62 | 43.37 |
Employee costs | -367.7 | -390.2 | -344.8 | -408.6 |
As % of sales | 21.15 | 19.23 | 17.34 | 16.88 |
Other costs | -501.2 | -527.4 | -529.9 | -643 |
As % of sales (Other Cost) | 28.83 | 26 | 26.64 | 26.57 |
Operating profit | 61.1 | 312.5 | 286 | 318.2 |
OPM | 3.51 | 15.4 | 14.38 | 13.15 |
Depreciation | -108.2 | -103.5 | -98 | -136.1 |
Interest expense | -0.4 | -0.4 | -1.2 | -1 |
Other income | 187.2 | 150.2 | 201.7 | 124.7 |
Profit before tax | 139.7 | 358.8 | 388.5 | 305.8 |
Taxes | -53.6 | -78.3 | -111.9 | -67.3 |
Tax rate | -38.36 | -21.82 | -28.8 | -22 |
Minorities and other | 0 | 0 | 4.6 | 0 |
Adj. profit | 86.1 | 280.5 | 281.2 | 238.5 |
Exceptional items | 0 | 0 | 159.7 | 0 |
Net profit | 86.1 | 280.5 | 440.9 | 238.5 |
yoy growth (%) | -69.3 | -36.38 | 84.86 | -54.07 |
NPM | 4.95 | 13.82 | 22.17 | 9.85 |
YESINTEK targets specific proteins that trigger inflammation, which presents new therapeutic options in the chronic management of autoimmune diseases.
Ethiopia, with a prevalence of 2-3%, is one of the top four nations in Sub-Saharan Africa for adult diabetics.
The combined cGMP inspection and pre-licensing inspection (PLI), which took place between July 15 and July 26, 2024, is the subject of this update.
Here are some of the stocks that may see significant price movement today: Tata Motors, Asian Paints, Divi’s Laboratories, etc.
The company's operating revenue climbed 3.7% to Rs 3,590.4 crore from Rs 3,462 crore in Q2 of FY24.
Here are some of the stocks that may see significant price movement today: Larsen & Toubro, Tata Power, Biocon, etc.
The inspection, which took place between September 23 and September 27, 2024, concluded with four observations from the regulatory organisation.
Here are some of the stocks that may see significant price movement today: Nuvama Wealth, RITES, Torrent Pharmaceuticals, etc.
The partnership focuses on commercializing GLP-1 (glucagon-like peptide-1) products for diabetes treatment and chronic weight management in the Middle East.
LIC's shareholding in Biocon has grown from 5,98,14,429 shares to 6,03,14,429 shares.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
